Achievement of treatment goals for primary prevention of cardiovascular disease in clinical practice across Europe: the EURIKA studyJosé R. Banegas, Fernando Rodríguez‐Artalejo, Esther López‐García et al.|European Heart Journal|2011Cited by 357
Medical and psychosocial factors and unfavourable low-density lipoprotein cholesterol control in coronary patientsJohn Munkhaugen, Einar Husebye, Jan Erik Otterstad et al.|European Journal of Preventive Cardiology|2017Cited by 47
The role of cardiac rehabilitation in secondary prevention after coronary eventsKari Peersen, Jan Erik Otterstad, John Munkhaugen et al.|European Journal of Preventive Cardiology|2017Cited by 46
The role of medical and psychosocial factors for unfavourable coronary risk factor controlJohn Munkhaugen, Toril Dammen, Elise Sverre et al.|Scandinavian Cardiovascular Journal|2015Cited by 28
Effect of atorvastatin on muscle symptoms in coronary heart disease patients with self-perceived statin muscle side effects: a randomized, double-blinded crossover trialOscar Kristiansen, John Munkhaugen, Nils Tore Vethe et al.|European Heart Journal - Cardiovascular Pharmacotherapy|2020Cited by 25